Stock and bond markets are sitting on a knife’s edge of doubt over the Trump administration’s tariffs and the impact of Congress’ budget bill on the federal deficit. Bond-rating agency Moody’s last week downgraded America’s credit worthiness.

President Trump on Friday revived his trade war, threatening to slap hefty tariffs on the European Union (E.U.) and to hit Apple with tariffs if it doesn’t manufacture in the United States. His moves represented an about-face after weeks in which markets had rallied to Trump’s pausing of his “Liberation Day” tariffs on much

Amgen is no exception to this dynamic. Although 2017's Tax Cuts and Jobs Act spurred the company to build a handful of new manufacturing sites within the U.S., it's still heavily reliant on its production facilities in Singapore and Ireland to make many of its drugs, including generics.

Tariffs are coming down, and the market is getting excited. Since the U.S. and China announced a tariff deal, the S&P 500 (SNPINDEX: ^GSPC) is up 5%, bringing it back into a year-to-date gain. U.S. companies are also still cautioning about how tariffs could affect their businesses.

BJ’s maintained its guidance while the broader retail sector is wrestling with the fallout from the Trump administration’s sweeping wave of tariffs.

Asian stocks rose early Friday as U.S. Treasury yields eased after a rocky week due to worries in the bond market over mounting U.S. government debt. The yield of the 10-year Treasury shed 0.6% to 4.52% while the two-year yield,

Thanks to Trump's tariffs, prices for guitars and other musical instruments are about to go up. That's bad news for beginners and pro musicians.

On Thursday, the company said it’ll handle the extra costs tied to the current tariff regime and still deliver its full-year earnings targets.